Anavex Life Sciences
AVXL
#6038
Rank
โ‚น62.63 B
Marketcap
โ‚น738.63
Share price
-2.99%
Change (1 day)
31.88%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น0.99 Billion

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are โ‚น0.99 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-09-30โ‚น1.04 B25.27%
2022-09-30โ‚น0.83 B3.7%
2021-09-30โ‚น0.80 B48.76%
2020-09-30โ‚น0.53 B51.84%
2019-09-30โ‚น0.35 B26.13%
2018-09-30โ‚น0.28 B20.33%
2017-09-30โ‚น0.23 B9.81%
2016-09-30โ‚น0.21 B21.53%
2015-09-30โ‚น0.17 B-60.2%
2014-09-30โ‚น0.44 B145.27%
2013-09-30โ‚น0.17 B17.72%
2012-09-30โ‚น0.15 B132.23%
2011-09-30โ‚น65.73 M-55.29%
2010-09-30โ‚น0.14 B-27.92%
2009-09-30โ‚น0.20 B90.36%
2008-09-30โ‚น0.10 B484.02%
2007-09-30โ‚น18.34 M1330.73%
2006-09-30โ‚น1.28 M8.13%
2005-09-30โ‚น1.18 M933.52%
2004-09-30โ‚น0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น7.69 B 675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น81.02 B 8,065.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.27 B 1,137.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.91 B-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA